Jan T Kielstein
Overview
Explore the profile of Jan T Kielstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
253
Citations
4624
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kielstein J
Wien Klin Mag
. 2023 Jun;
:1-6.
PMID: 37359739
In addition to kidney replacement procedures, several other extracorporeal procedures are employed in the intensive care unit. Hemoperfusion with activated charcoal was the predominant treatment used for removal of toxins...
12.
David S, Russell L, Castro P, van de Louw A, Zafrani L, Pirani T, et al.
Intensive Care Med Exp
. 2023 May;
11(1):26.
PMID: 37150798
Therapeutic plasma exchange (TPE) is a therapeutic intervention that separates plasma from blood cells to remove pathological factors or to replenish deficient factors. The use of TPE is increasing over...
13.
Chen S, Martens-Lobenhoffer J, Weissenborn K, Kielstein J, Lichtinghagen R, Deb-Chatterji M, et al.
J Neuroinflammation
. 2023 May;
20(1):103.
PMID: 37131264
No abstract available.
14.
Beutel G, Geerits E, Kielstein J
Crit Care
. 2023 Apr;
27(1):148.
PMID: 37072798
No abstract available.
15.
Seffer M, Weinert M, Molinari G, Rohde M, Grobe L, Kielstein J, et al.
PLoS One
. 2023 Mar;
18(3):e0283304.
PMID: 36930680
Introduction: Extracorporeal blood purification systems represent a promising alternative for treatment of blood stream infections with multiresistant bacteria. Objectives: The aim of this study was to analyse the binding activity...
16.
Pfenning M, Schmitz J, Scheffner I, Schulte K, Khalifa A, Tezval H, et al.
Kidney Int Rep
. 2023 Feb;
8(2):341-356.
PMID: 36815108
Introduction: Macrophages and monocytes are main players in innate immunity. The relevance of mononuclear phagocyte infiltrates on clinical outcomes remains to be determined in native kidney diseases. Methods: Our cross-sectional...
17.
Lehmann K, Diab S, Meyer T, Kielstein J, Eden G
Case Rep Nephrol Dial
. 2022 Dec;
12(3):145-149.
PMID: 36518357
In parallel with the decline of renal excretory function, drug dosing of many drugs becomes more challenging. Finding the right dose is even more difficult if kidney replacement therapy is...
18.
Dennhardt S, Pirschel W, Wissuwa B, Imhof D, Daniel C, Kielstein J, et al.
Front Immunol
. 2022 Oct;
13:1010882.
PMID: 36211426
Hemolytic-uremic syndrome (HUS) can occur as a systemic complication of infections with Shiga toxin (Stx)-producing and is characterized by microangiopathic hemolytic anemia and acute kidney injury. Hitherto, therapy has been...
19.
Zarbock A, Kielstein J
Crit Care Med
. 2022 Aug;
50(9):e740-e741.
PMID: 35984075
No abstract available.
20.
Andermatt R, Bloemberg G, Ganter C, Mueller N, Mueller A, Muellhaupt B, et al.
Crit Care Explor
. 2022 Aug;
4(8):e0745.
PMID: 35975141
Design: Explorative study. Setting: Academic tertiary care transplant center. Patient: Single patient with HSV-2-induced ALF. Interventions: TPE + Seraph 100 Microbind Affinity Blood Filter. Measurements And Main Results: We report...